|
Mr. Skolas has previously served as Chief Financial Officer at three development stage biotechnology companies, ValiGen N.V, Coelacanth Corporation, and PhytoWorks, Incorporated. From 1988 to 1999 he served in various capacities at EMI Group Inc., a subsidiary of EMI Group plc, including five years as President for the Americas. EMI Group Inc. operated as a shared services subsidiary and corporate office, providing treasury, finance, tax, insurance, M&A, legal and other services to US subsidiaries of EMI Group plc. Prior to joining EMI Group Inc., Mr. Skolas was a partner in a private law firm. He holds a J.D. from the University of Wisconsin, an M.B.A. from Harvard Business School, and holds a CPA certificate from the Iowa Board of Accountancy. | 